Abigail Mallon’s role is to lead the company’s strategic account teams, while guiding emerging business strategy and leveraging execution capabilities within the company. She provides the strategic direction, thought leadership, and vision necessary to innovate on all client-facing products and services.

Serving as Chief Compliance Officer for VMS, Abigail has in-depth knowledge of pharma-related compliance laws and regulations across a wide variety of therapeutic areas and brands. She is the company’s expert on regulatory compliance issues and privacy.

Abigail has played an instrumental role in the growth of VMS with more than 20 years of marketing experience in the healthcare and pharmaceutical industry developing and executing Clinical Nurse Educator programs. She led the development and execution of the company's first Clinical Educator network to provide patient support programs, and she has since overseen the journey to the current offering of multiple networks and programs across numerous device, pharmaceutical, and healthcare brands.

A seasoned executive with bio brands, Abigail is a frequent speaker and panelist on patient adherence topics, Clinical Nurse Educator solutions, compliance, and patient support services at pharma industry conferences. She has developed a product innovation program at VMS that includes a handbook of tools and regular labs that create a culture of innovation. She works constantly to stay on top of patient needs and market trends that drive innovation in providing best-in-class Clinical Nurse Educator solutions.

Abigail earned a bachelor’s degree from Indiana University, majoring in psychology. She has been a contributor to PM360 magazine, FirstWord Pharma, Pharmaceutical Executive Magazine, and Medical Meetings Magazine, and she is a former executive board member and vice president of the Indiana and Chicago chapters of the Healthcare Businesswomen's Association (HBA). She currently serves as a member of the Executive Advisory Council for the Indiana HBA chapter. She was named an HBA Luminary in 2019.